142 related articles for article (PubMed ID: 32305587)
1. Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
Lee SH; Son H; Peck KR
Int J Antimicrob Agents; 2020 Jun; 55(6):105988. PubMed ID: 32305587
[TBL] [Abstract][Full Text] [Related]
2. The issue of decisiveness in the COVID-19 outbreak in Korea.
Ha KM
Clin Med (Lond); 2021 Nov; 21(6):e680-e681. PubMed ID: 34862235
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: Time for Post-Exposure Prophylaxis?
Gentile I; Maraolo AE; Piscitelli P; Colao A
Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32512873
[TBL] [Abstract][Full Text] [Related]
5. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
Million M; Lagier JC; Gautret P; Colson P; Fournier PE; Amrane S; Hocquart M; Mailhe M; Esteves-Vieira V; Doudier B; Aubry C; Correard F; Giraud-Gatineau A; Roussel Y; Berenger C; Cassir N; Seng P; Zandotti C; Dhiver C; Ravaux I; Tomei C; Eldin C; Tissot-Dupont H; Honoré S; Stein A; Jacquier A; Deharo JC; Chabrière E; Levasseur A; Fenollar F; Rolain JM; Obadia Y; Brouqui P; Drancourt M; La Scola B; Parola P; Raoult D
Travel Med Infect Dis; 2020; 35():101738. PubMed ID: 32387409
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Boulware DR; Pullen MF; Bangdiwala AS; Pastick KA; Lofgren SM; Okafor EC; Skipper CP; Nascene AA; Nicol MR; Abassi M; Engen NW; Cheng MP; LaBar D; Lother SA; MacKenzie LJ; Drobot G; Marten N; Zarychanski R; Kelly LE; Schwartz IS; McDonald EG; Rajasingham R; Lee TC; Hullsiek KH
N Engl J Med; 2020 Aug; 383(6):517-525. PubMed ID: 32492293
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
Abella BS; Jolkovsky EL; Biney BT; Uspal JE; Hyman MC; Frank I; Hensley SE; Gill S; Vogl DT; Maillard I; Babushok DV; Huang AC; Nasta SD; Walsh JC; Wiletyo EP; Gimotty PA; Milone MC; Amaravadi RK;
JAMA Intern Med; 2021 Feb; 181(2):195-202. PubMed ID: 33001138
[TBL] [Abstract][Full Text] [Related]
9. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
Rosenberg ES; Dufort EM; Udo T; Wilberschied LA; Kumar J; Tesoriero J; Weinberg P; Kirkwood J; Muse A; DeHovitz J; Blog DS; Hutton B; Holtgrave DR; Zucker HA
JAMA; 2020 Jun; 323(24):2493-2502. PubMed ID: 32392282
[TBL] [Abstract][Full Text] [Related]
10. Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study.
Dhibar DP; Arora N; Kakkar A; Singla N; Mohindra R; Suri V; Bhalla A; Sharma N; Singh MP; Prakash A; Pvm L; Medhi B
Int J Antimicrob Agents; 2020 Dec; 56(6):106224. PubMed ID: 33166694
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
Rajasingham R; Bangdiwala AS; Nicol MR; Skipper CP; Pastick KA; Axelrod ML; Pullen MF; Nascene AA; Williams DA; Engen NW; Okafor EC; Rini BI; Mayer IA; McDonald EG; Lee TC; Li P; MacKenzie LJ; Balko JM; Dunlop SJ; Hullsiek KH; Boulware DR; Lofgren SM;
Clin Infect Dis; 2021 Jun; 72(11):e835-e843. PubMed ID: 33068425
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine for post-exposure prophylaxis of COVID-19 among naval personnel in Sri Lanka: study protocol for a randomized, controlled trial.
Niriella MA; Ediriweera DS; De Silva AP; Premarathne R; Balasooriya P; Duminda KD; Malavige NG; Wanigasuriya K; Lekamwasam S; Kularathne SA; Siribaddana S; de Silva HJ; Jayasinghe S
Trials; 2020 Aug; 21(1):748. PubMed ID: 32854751
[TBL] [Abstract][Full Text] [Related]
14. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Self WH; Semler MW; Leither LM; Casey JD; Angus DC; Brower RG; Chang SY; Collins SP; Eppensteiner JC; Filbin MR; Files DC; Gibbs KW; Ginde AA; Gong MN; Harrell FE; Hayden DL; Hough CL; Johnson NJ; Khan A; Lindsell CJ; Matthay MA; Moss M; Park PK; Rice TW; Robinson BRH; Schoenfeld DA; Shapiro NI; Steingrub JS; Ulysse CA; Weissman A; Yealy DM; Thompson BT; Brown SM; ; Steingrub J; Smithline H; Tiru B; Tidswell M; Kozikowski L; Thornton-Thompson S; De Souza L; Hou P; Baron R; Massaro A; Aisiku I; Fredenburgh L; Seethala R; Johnsky L; Riker R; Seder D; May T; Baumann M; Eldridge A; Lord C; Shapiro N; Talmor D; O’Mara T; Kirk C; Harrison K; Kurt L; Schermerhorn M; Banner-Goodspeed V; Boyle K; Dubosh N; Filbin M; Hibbert K; Parry B; Lavin-Parsons K; Pulido N; Lilley B; Lodenstein C; Margolin J; Brait K; Jones A; Galbraith J; Peacock R; Nandi U; Wachs T; Matthay M; Liu K; Kangelaris K; Wang R; Calfee C; Yee K; Hendey G; Chang S; Lim G; Qadir N; Tam A; Beutler R; Levitt J; Wilson J; Rogers A; Vojnik R; Roque J; Albertson T; Chenoweth J; Adams J; Pearson S; Juarez M; Almasri E; Fayed M; Hughes A; Hillard S; Huebinger R; Wang H; Vidales E; Patel B; Ginde A; Moss M; Baduashvili A; McKeehan J; Finck L; Higgins C; Howell M; Douglas I; Haukoos J; Hiller T; Lyle C; Cupelo A; Caruso E; Camacho C; Gravitz S; Finigan J; Griesmer C; Park P; Hyzy R; Nelson K; McDonough K; Olbrich N; Williams M; Kapoor R; Nash J; Willig M; Ford H; Gardner-Gray J; Ramesh M; Moses M; Ng Gong M; Aboodi M; Asghar A; Amosu O; Torres M; Kaur S; Chen JT; Hope A; Lopez B; Rosales K; Young You J; Mosier J; Hypes C; Natt B; Borg B; Salvagio Campbell E; Hite RD; Hudock K; Cresie A; Alhasan F; Gomez-Arroyo J; Duggal A; Mehkri O; Hastings A; Sahoo D; Abi Fadel F; Gole S; Shaner V; Wimer A; Meli Y; King A; Terndrup T; Exline M; Pannu S; Robart E; Karow S; Hough C; Robinson B; Johnson N; Henning D; Campo M; Gundel S; Seghal S; Katsandres S; Dean S; Khan A; Krol O; Jouzestani M; Huynh P; Weissman A; Yealy D; Scholl D; Adams P; McVerry B; Huang D; Angus D; Schooler J; Moore S; Files C; Miller C; Gibbs K; LaRose M; Flores L; Koehler L; Morse C; Sanders J; Langford C; Nanney K; MdalaGausi M; Yeboah P; Morris P; Sturgill J; Seif S; Cassity E; Dhar S; de Wit M; Mason J; Goodwin A; Hall G; Grady A; Chamberlain A; Brown S; Bledsoe J; Leither L; Peltan I; Starr N; Fergus M; Aston V; Montgomery Q; Smith R; Merrill M; Brown K; Armbruster B; Harris E; Middleton E; Paine R; Johnson S; Barrios M; Eppensteiner J; Limkakeng A; McGowan L; Porter T; Bouffler A; Leahy JC; deBoisblanc B; Lammi M; Happel K; Lauto P; Self W; Casey J; Semler M; Collins S; Harrell F; Lindsell C; Rice T; Stubblefield W; Gray C; Johnson J; Roth M; Hays M; Torr D; Zakaria A; Schoenfeld D; Thompson T; Hayden D; Ringwood N; Oldmixon C; Ulysse C; Morse R; Muzikansky A; Fitzgerald L; Whitaker S; Lagakos A; Brower R; Reineck L; Aggarwal N; Bienstock K; Freemer M; Maclawiw M; Weinmann G; Morrison L; Gillespie M; Kryscio R; Brodie D; Zareba W; Rompalo A; Boeckh M; Parsons P; Christie J; Hall J; Horton N; Zoloth L; Dickert N; Diercks D
JAMA; 2020 Dec; 324(21):2165-2176. PubMed ID: 33165621
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
Cavalcanti AB; Zampieri FG; Rosa RG; Azevedo LCP; Veiga VC; Avezum A; Damiani LP; Marcadenti A; Kawano-Dourado L; Lisboa T; Junqueira DLM; de Barros E Silva PGM; Tramujas L; Abreu-Silva EO; Laranjeira LN; Soares AT; Echenique LS; Pereira AJ; Freitas FGR; Gebara OCE; Dantas VCS; Furtado RHM; Milan EP; Golin NA; Cardoso FF; Maia IS; Hoffmann Filho CR; Kormann APM; Amazonas RB; Bocchi de Oliveira MF; Serpa-Neto A; Falavigna M; Lopes RD; Machado FR; Berwanger O;
N Engl J Med; 2020 Nov; 383(21):2041-2052. PubMed ID: 32706953
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.
Mitjà O; Corbacho-Monné M; Ubals M; Tebé C; Peñafiel J; Tobias A; Ballana E; Alemany A; Riera-Martí N; Pérez CA; Suñer C; Laporte P; Admella P; Mitjà J; Clua M; Bertran L; Sarquella M; Gavilán S; Ara J; Argimon JM; Casabona J; Cuatrecasas G; Cañadas P; Elizalde-Torrent A; Fabregat R; Farré M; Forcada A; Flores-Mateo G; Muntada E; Nadal N; Narejos S; Nieto A; Prat N; Puig J; Quiñones C; Reyes-Ureña J; Ramírez-Viaplana F; Ruiz L; Riveira-Muñoz E; Sierra A; Velasco C; Vivanco-Hidalgo RM; Sentís A; G-Beiras C; Clotet B; Vall-Mayans M
Clin Infect Dis; 2021 Dec; 73(11):e4073-e4081. PubMed ID: 32674126
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
Skipper CP; Pastick KA; Engen NW; Bangdiwala AS; Abassi M; Lofgren SM; Williams DA; Okafor EC; Pullen MF; Nicol MR; Nascene AA; Hullsiek KH; Cheng MP; Luke D; Lother SA; MacKenzie LJ; Drobot G; Kelly LE; Schwartz IS; Zarychanski R; McDonald EG; Lee TC; Rajasingham R; Boulware DR
Ann Intern Med; 2020 Oct; 173(8):623-631. PubMed ID: 32673060
[TBL] [Abstract][Full Text] [Related]
19. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
Chatterjee P; Anand T; Singh KJ; Rasaily R; Singh R; Das S; Singh H; Praharaj I; Gangakhedkar RR; Bhargava B; Panda S
Indian J Med Res; 2020 May; 151(5):459-467. PubMed ID: 32611916
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
